Inverted balloon system and inflation management system

Information

  • Patent Grant
  • 11159876
  • Patent Number
    11,159,876
  • Date Filed
    Friday, August 23, 2019
    5 years ago
  • Date Issued
    Tuesday, October 26, 2021
    3 years ago
Abstract
At least one exemplary embodiment is directed to an earpiece having a balloon and a stent where the balloon is mounted on the stent and the stent incorporates two or more channels including at least an inflation channel and an acoustic channel. In some embodiments the stent is configured to pass audio signals through the acoustic channel where the acoustic channel is independent of the inflation channel of the balloon. Other embodiments are disclosed.
Description
FIELD OF THE INVENTION

The embodiments relate in general to pressure management and balloon bonds, and particularly though not exclusively, is related to creating a pressure management system for earpiece systems.


BACKGROUND

Inflatable acoustic systems using balloons can have difficulties in maintaining the bonding of a balloon to a stent upon insertion. In addition there is no pressure management system that has been designed for an inflatable earpiece.


SUMMARY

At least one exemplary embodiment is directed to a method of invert bonding of a balloon comprising: bonding a sheath balloon to a stent at a first bond location, where the sheath balloon has first surface and a second surface, where the bonding at the first bond location is between the stent and a portion of the first surface, where the first surface faces the stent; pulling the sheath balloon from an unbounded end over the first bond to a chosen second bond location so that the first surface faces away from the stent forming an inverted bond at the first bond location; and bonding the sheath at the second bond location where the bonding at the second bond location is between the stent and a portion of the second surface.


At least one exemplary embodiment is directed to a method of forming an inverted bond balloon comprising: aligning a mold core with a first and a second mold shell, where the first shell has an injection port, where the first and second mold shell and the mold core are aligned using alignment recesses and pins, where when the mold core is aligned there is a gap between a portion of the mold core and the first and second mold shells, where the gap is designed to be related to a molded balloon thickness; aligning the injection port with an injection nozzle; clamping a mold against an injection nozzle; inserting a flexible material into the mold through the injection port of the mold; removing the mold from the injection nozzle; curing the material in the mold, where curing can be at least one of cooling, UV illumination, and chemical reaction; and opening the mold and removing a molded balloon with at least one inverted bond, where the molded balloon is configured so that when attached to a stent and inflated the inverted bond presses against a stent.


At least one exemplary embodiment is directed to an inverted bond balloon stent comprising: a balloon bonded to a stent, where the balloon has at least one end of the balloon inverted bonded to the stent; and a stent, where the stent is configured to provide one of air and liquid to the balloon.


At least one exemplary embodiment is directed to a pressure management system for an earpiece comprising: a first valve, where the first valve allows air to pass from a first side of the valve to a second side more readily than from the second side to the first side; an inflation channel, where the inflation channel has an outer diameter less than 5 mm; a pressure release mechanism; a pump; a stent, where the inflation channel is embedded; and a balloon, where the first valve, the inflation channel, the pressure release mechanism, the pump, and the balloon are operatively connected, where the first valve is positioned so that air from the pump passes through the first valve to inflate the balloon and where the leak rate of the air from the balloon back to the pump is less than 1% by volume per minute and where the pressure release mechanism is configured to release pressure from the balloon to the environment upon actuation, and where the pressure management system is configured to manage the inflation pressure of the balloon in an orifice.





BRIEF DESCRIPTION OF THE DRAWINGS

Exemplary embodiments of present invention will become more fully understood from the detailed description and the accompanying drawings, wherein:



FIGS. 1 through 4 illustrate a method of bonding a balloon sheath to a stent to form an inverted bond in accordance with at least one exemplary embodiment;



FIG. 5 illustrates an inflated balloon having an inverted bond in accordance with at least one exemplary embodiment.



FIG. 6 illustrates the restoring force associated with an inverted bond of a balloon in accordance with at least one exemplary embodiment;



FIG. 7 illustrates a core mold associated with the molding of a balloon with an inverted bond in accordance with at least one exemplary embodiment;



FIG. 8 illustrates the core mold inserted into one shell mold in accordance with at least one exemplary embodiment;



FIG. 9 illustrates a core mold inserted into two shell molds in accordance with at least one exemplary embodiment;



FIG. 10 illustrates a pressure management system also referred to as an inflation management system (IMS) in accordance with at least one exemplary embodiment;



FIG. 11 illustrates a block diagram of an IMS system using a manual pump in accordance with at least one exemplary embodiment;



FIG. 12 illustrates a block diagram of an IMS system using a automated pump in accordance with at least one exemplary embodiment; and



FIG. 13 illustrates a diagram of an restoring membrane based IMS in accordance with at least one exemplary embodiment.





DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS OF THE PRESENT INVENTION

The following description of exemplary embodiment(s) is merely illustrative in nature and is in no way intended to limit the invention, its application, or uses.


Processes, techniques, apparatus, and materials as known by one of ordinary skill in the art may not be discussed in detail but are intended to be part of the enabling description where appropriate. For example specific computer code may not be listed for achieving each of the steps discussed, however one of ordinary skill would be able, without undo experimentation, to write such code given the enabling disclosure herein. Such code is intended to fall within the scope of at least one exemplary embodiment.


Additionally, the sizes of structures used in exemplary embodiments are not limited by any discussion herein (e.g., the sizes of structures can be macro (centimeter, meter, and size), micro (micro meter), nanometer size and smaller).


Notice that similar reference numerals and letters refer to similar items in the following figures, and thus once an item is defined in one figure, it may not be discussed or further defined in the following figures.


In all of the examples illustrated and discussed herein, any specific values, should be interpreted to be illustrative only and non-limiting. Thus, other examples of the exemplary embodiments could have different values.


Additionally various materials can be used for inflations channels, stents, acoustic channels, valves, balloons and pressure release mechanism. For example for examples for the stent, valves, inflation channels, and balloons a material that has a low permeability to the medium in the balloon can be used. For example Teflon can be used for an air medium. The type of material will be governed by the design criteria. For example a flexible material that has an air permeability of less than 5% loss of volume in 6 hours is SARLINK™.



FIGS. 1 through 4 illustrate a method of bonding a balloon sheath to a stent to form an inverted bond in accordance with at least one exemplary embodiment. At least one exemplary embodiment is directed to a method of invert bonding of a balloon comprising: bonding a sheath balloon 110 (e.g., of SARLINK.™. or other materials that have a low permeability to the medium (air and liquid) in the balloon) to a stent (e.g., which can be made of the same material as the balloon and which can also have a low permeability (e.g., loss of medium by volume is less than 3% in a 16 hour period) at a first bond location 120 (e.g., at the stent tip and extending inward a distance for example about 1 mm), where the sheath balloon has first surface and a second surface, where the bonding (e.g., adhesive bonding, thermal bonding, UV curing bonding, or molding the balloon and stent as one piece) at the first bond location is between the stent and a portion of the first surface, where the first surface faces the stent (FIGS. 1 and 2, where the stent 100 can have an acoustic channel 105); pulling (e.g., pulling from A in the direction of 130) the sheath balloon from an unbounded end over the first bond (from A to B, FIGS. 3 and 4) to a chosen second bond location (B) (FIG. 3) so that the first surface faces away from the stent forming an inverted bond at the first bond location; and bonding the sheath at the second bond location where the bonding (170, FIG. 5) at the second bond location is between the stent and a portion of the second surface.


Note the bond strengths are such that various balloon pressures can be maintained. For example an internal gauge pressure between 0.05 bar to 3 bar. FIG. 5 illustrates an inflated balloon 120, expanded in accordance to at least one exemplary embodiment. Note that the tip is nearly obscured (the forward portion of the inflated balloon can vary in length, it can extent completely over (e.g. align with the tip or extent over several mms) the tip (through which 105 is shown) to recessed (e.g., 1 mm from the tip) in the radial direction from the expanding balloon.



FIG. 6 illustrates how an inflated balloon with an inverted bond has the pressure presses the bond (e.g., 620) to the stent rather than try and separate the balloon from the stent as the exterior pressure (610) would do if there were not an inverted bond. This allows some force to be exerted along and/or radial to the stent on the balloon 120. Note in FIG. 6 only one inverted bond is shown (e.g., bond 170 is not an inverted bond), however at least one exemplary embodiment has bond 170 also replaced with an inverted bond, in such a situation the sheath would be moved from B to A slightly and the B end flipped to form an inverted bond.


In addition to bonding a sheath balloon on a stent to form an inverted bond, an inverted bond can be molded (see FIGS. 7, 8, and 9).



FIGS. 7, 8, and 9 illustrate a mold that can be used in a method of forming an inverted bond balloon. For example at least one exemplary embodiment if directed to a method of molding a balloon with an inverted bond comprising: aligning a mold core with a first and a second mold shell (750, 790), where the first shell has an injection port (760), where the first and second mold shell and the mold core are aligned using alignment recesses (710, 720) and pins (710A, 720A), where when the mold core is aligned there is a gap between a portion of the mold core and the first and second mold shells, where the gap (730) is designed to be related to a molded balloon thickness (e.g., 0.1 mm); aligning the injection port 760 with an injection nozzle; clamping a mold against an injection nozzle; inserting a flexible material into the mold through the injection port of the mold; removing the mold from the injection nozzle; curing the material in the mold, where curing can be at least one of cooling, UV illumination, and chemical reaction; and opening the mold and removing a molded balloon with at least one inverted bond, where the molded balloon is configured so that when attached to a stent and inflated the inverted bond presses against a stent.


Note that the gap 730 can be variable throughout the mold allowing one to mold variable thickness balloons. For example a region of the balloon that one would want to expand first can be thinner than another part of the balloon. Note that the material that can be used for molding can (besides satisfying the design permeability requirement set during design) be flexible. Note that the flexible material can have a linear elongation of greater than 100% without deformation of more than 5% in the area of the balloon when deflated. Some sample materials are SARLINK.™.


Note that the stent can be connected to microphones, where some can sample the ambient environment (ASM 1150), some sampling the ear canal (ECM, 1170) and receivers, some playing acoustic energy into the ear canal (ECR 1160). Note various microphones and receivers can be used, for example Knowles MEM microphones, TO and FG microphones, and TWFK receivers.



FIGS. 10 through 13 illustrate inflation management systems (also referred to as pressure management systems) in accordance with at least a few exemplary embodiments. For example at least one exemplary embodiment is directed to a pressure management system (e.g., 1090, 1100, 1200) for an earpiece (e.g., a device that is designed to be used with any part of the ear) comprising: a first valve (e.g., duck valves, one way valves, 1030, 1130A-1130F), where the first valve allows air to pass from a first side of the valve to a second side more readily than from the second side to the first side; an inflation channel, where the inflation channel has an outer diameter less than the size of an orifice in which it is to be inserted (e.g., <5 mm); a pressure release mechanism (e.g., a pin to push open the valve 1030); a pump (e.g., a manual pump (e.g., bladder), automatic pump (e.g., linear actuator) a stent, where the inflation channel is embedded; and a balloon, where the first valve, the inflation channel, the pressure release mechanism, the pump, and the balloon are operatively connected, where the first valve is positioned so that air from the pump passes through the first valve to inflate the balloon and where the leak rate of the air from the balloon back to the pump is less than 1% by volume per minute and where the pressure release mechanism is configured to release pressure from the balloon to the environment upon actuation, and where the pressure management system is configured to manage the inflation pressure of the balloon in an orifice.


Note that the stent can be as large as the inflation tube or larger.


Note that at least one exemplary embodiment can include a second valve to release pressure when the pressure in the balloon exceeds a design threshold (e.g., between 0.05 bar gauge to 3 bar gauge).


Note also that FIGS. 11 and 12 illustrate detachable stents and balloon systems (ear manifold 1120) from the remaining elements (instrument package 1111). A valve in the stent 1130C can allow the one way passage of medium into the balloon (e.g., inflation element 1180). A second valve 130D can release pressure if it gets above a certain value. For example if the gauge pressure exceeds 0.25 bar gauge. Note that the pump can also be connected to a release valve 1130F. For an automated pump a power source 1210 (e.g. battery) can power the pump 1130.



FIG. 13 illustrates a restoring membrane exemplary embodiment, where an inflated balloon 1330, when pressed (e.g., via ear canal wall) exerts pressure on a restoring membrane 1320. The restoring membrane can provide a restoring force 1310A, which is felt by the balloon 13108 so that when the balloon is no longer pressed it will expand back to an equilibrium position. The restoring membrane can be one that has a higher elastic elongation than the balloon material, or be thinner. The restoring membrane and balloon can be pneumatically coupled 1350 through the stent 100.


Note that an earpiece can include an Ambient Sound Microphone (ASM) to capture ambient sound, an Ear Canal Receiver (ECR) to deliver audio to an ear canal and an Ear Canal Microphone (ECM) to capture and assess a sound exposure level within the ear canal. The earpiece can partially or fully occlude the ear canal to provide various degrees of acoustic isolation. In at least one exemplary embodiment, assembly is designed to be inserted into the user's ear canal, and to form an acoustic seal with the walls of the ear canal at a location between the entrance to the ear canal and the tympanic membrane (or ear drum). In general, such a seal is typically achieved by means of the balloon.


While the present invention has been described with reference to exemplary embodiments, it is to be understood that the invention is not limited to the disclosed exemplary embodiments. The scope of the following claims is to be accorded the broadest interpretation so as to encompass all such modifications and equivalent structures and functions.

Claims
  • 1. An eartip comprising: a sealed element where the sealed element encompasses a first chamber, where the first chamber is connected to a second chamber that is part of an earphone, where the second chamber is encompassed by a flexible membrane and where the second and the first chamber form a sealed system when connected together, whereupon when the sealed element is deformed the flexible membrane is deformed providing a restoring force to the sealed element; anda stent, where the sealed element is attached to the stent, where the stent is configured to be attached to and removable from the earphone, where the stent includes a first and second acoustic channel, where the first acoustic channel is configured to be coupled to a microphone and the second acoustic channel is configured to be coupled to a speaker when the eartip is connected to the earphone, where the earphone is wirelessly connected to a communication device.
  • 2. The eartip according to claim 1, where the sealed element is composed of a flexible material.
  • 3. The eartip according to claim 2, where the sealed element encloses a gas.
  • 4. The eartip according to claim 3, where the gas passes between the first chamber and the second chamber.
  • 5. The eartip according to claim 4, where the eartip is configured so that when the first chamber is deformed it forces gas from the first chamber to the second chamber.
  • 6. The eartip according to claim 5, where the second chamber is deformed when the gas from the first chamber is forced from the first chamber to the second chamber.
  • 7. The eartip according to claim 2, where the sealed element encloses a liquid.
  • 8. The eartip according to claim 2, where the sealed element is made from silicone.
  • 9. The eartip according to claim 2, where the first chamber has a first elongation value and the second chamber has a second elongation value, where the first elongation value is greater than the second elongation value.
  • 10. The eartip according to claim 9, where the first elongation value is greater than 100%.
  • 11. The eartip according to claim 2, where the first chamber has a first elongation value and the second chamber has a second elongation value, where the first elongation value is less than the second elongation value.
  • 12. The eartip according to claim 11, where the first elongation value is less than 50%.
  • 13. The eartip according to claim 1 where the second chamber is connected to the first chamber by an inflation channel passing through the stent when the earphone is connected to the eartip.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 15/791,038 filed on 23 Oct. 2017 which is a continuation of U.S. application Ser. No. 14/669,602 filed on 26 Mar. 2015 which is a continuation of Ser. No. 12/578,461 filed 13 Oct. 2009 (U.S. Pat. No. 8,992,710 issued 31 Mar. 2015) and further claims the benefit of U.S. provisional patent application No. 61/103,923 filed 10 Oct. 2008. The disclosure of the aforementioned applications are incorporated herein by reference in their entirety.

US Referenced Citations (84)
Number Name Date Kind
2535258 Bland Dec 1950 A
3602654 Victoreen Aug 1971 A
4029083 Baylor Jun 1977 A
4133984 Akiyama Jan 1979 A
4741344 Danby et al. May 1988 A
4834211 Bibby May 1989 A
4896679 St. Pierre Jan 1990 A
4962537 Basel et al. Oct 1990 A
5333622 Casali et al. Aug 1994 A
5483027 Krause Jan 1996 A
5697375 Hickey Dec 1997 A
6094494 Haroldson Jul 2000 A
6256396 Cushman Jul 2001 B1
6339648 McIntosh et al. Jan 2002 B1
6393130 Stonikas et al. May 2002 B1
6671381 Lux-Wellenhof Dec 2003 B1
7130437 Stonikas et al. Oct 2006 B2
7164775 Meyer et al. Jan 2007 B2
7227968 van Halteren et al. Jun 2007 B2
7362875 Saxton et al. Apr 2008 B2
7387187 Widmer et al. Jun 2008 B2
7625371 Morris et al. Dec 2009 B2
7756281 Goldstein et al. Jul 2010 B2
8038629 Solanki et al. Oct 2011 B2
8047207 Perez et al. Nov 2011 B2
8194864 Goldstein et al. Jun 2012 B2
8199919 Goldstein et al. Jun 2012 B2
8208644 Goldstein et al. Jun 2012 B2
8208652 Keady Jun 2012 B2
8221861 Keady Jul 2012 B2
8229128 Keady Jul 2012 B2
8246533 Chang et al. Aug 2012 B2
8251925 Keady et al. Aug 2012 B2
8312960 Keady Nov 2012 B2
8398623 Warnking et al. Mar 2013 B2
8437492 Goldstein et al. May 2013 B2
8550206 Keady et al. Oct 2013 B2
8554350 Keady et al. Oct 2013 B2
8600067 Usher et al. Dec 2013 B2
8617152 Werneth et al. Dec 2013 B2
8631801 Keady Jan 2014 B2
8657064 Staab et al. Feb 2014 B2
8678011 Goldstein et al. Mar 2014 B2
8718313 Keady May 2014 B2
8808322 Jones et al. Aug 2014 B2
8834461 Werneth et al. Sep 2014 B2
8848939 Keady et al. Sep 2014 B2
8880195 Asure Nov 2014 B2
8917880 Goldstein et al. Dec 2014 B2
8992710 Keady Mar 2015 B2
9113267 Usher et al. Aug 2015 B2
9123323 Keady Sep 2015 B2
9138353 Keady Sep 2015 B2
9185481 Goldstein et al. Nov 2015 B2
9216237 Keady Dec 2015 B2
9539147 Keady et al. Jan 2017 B2
9757069 Keady et al. Sep 2017 B2
9781530 Usher et al. Oct 2017 B2
9843854 Keady Dec 2017 B2
10012529 Goldstein et al. Jul 2018 B2
10190904 Goldstein et al. Jan 2019 B2
20010043708 Brimhall Nov 2001 A1
20020196958 Halteren et al. Dec 2002 A1
20030023204 Vo et al. Jan 2003 A1
20060159298 von Dombrowski et al. Jul 2006 A1
20070116319 Hagberg May 2007 A1
20080144871 Purcell et al. Jun 2008 A1
20090071487 Keady Mar 2009 A1
20090173353 Purcell et al. Jul 2009 A1
20090320858 Purcell et al. Dec 2009 A1
20090320859 Purcell et al. Dec 2009 A1
20100241256 Goldstein et al. Sep 2010 A1
20130098706 Keady Apr 2013 A1
20130149192 Keady Jun 2013 A1
20140003644 Keady et al. Jan 2014 A1
20140026665 Keady Jan 2014 A1
20140373854 Keady Dec 2014 A1
20160015568 Keady Jan 2016 A1
20160192077 Keady Jun 2016 A1
20160295311 Keady et al. Oct 2016 A1
20170134865 Goldstein et al. May 2017 A1
20180132048 Usher et al. May 2018 A1
20180220239 Keady et al. Aug 2018 A1
20190082272 Goldstein et al. Mar 2019 A9
Related Publications (1)
Number Date Country
20190387305 A1 Dec 2019 US
Provisional Applications (1)
Number Date Country
61103923 Oct 2008 US
Continuations (3)
Number Date Country
Parent 15791038 Oct 2017 US
Child 16549410 US
Parent 14669602 Mar 2015 US
Child 15791038 US
Parent 12578461 Oct 2009 US
Child 14669602 US